about
Obesity and adipokines: effects on sympathetic overactivityPhysiology of kidney reninLeptin decreases heart rate associated with increased ventricular repolarization via its receptorNGF gene expression and secretion in white adipose tissue: regulation in 3T3-L1 adipocytes by hormones and inflammatory cytokinesLeptin and the adrenal gland.Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats.Weight reduction and obesity.Leptin deficiency recapitulates the histological features of pulmonary arterial hypertension in mice.Physiological roles of the leptin endocrine system: differences between mice and humans.Role of sympathetic nervous system and neuropeptides in obesity hypertension.Does leptin predict incident hypertension in older adults?Enhanced blood pressure and appetite responses to chronic central melanocortin-3/4 receptor blockade in dietary-induced obesity.Innervation of skeletal muscle by leptin receptor-containing neuronsGene-environment interactions in hypertension.Obesity, hypertension, and sympathetic nervous system activity.Sympathetic nervous system, diabetes, and hypertension.Leptin stimulates sympathetic axon outgrowthAdipocyte apoptosis in the regulation of body fat mass by leptin.Activation of the cardiac ciliary neurotrophic factor receptor reverses left ventricular hypertrophy in leptin-deficient and leptin-resistant obesity.Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidneyAppetite and energy balance signals from adipocytes.PI3Kγ within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance.Leptin: sympathetic and cardiovascular effects.Brain-mediated antidiabetic, anorexic, and cardiovascular actions of leptin require melanocortin-4 receptor signaling.Leptin, sympathetic nervous system, and baroreflex function.Leptin in anorexia and cachexia syndrome.Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats.Adipokines and blood pressure controlLeptin and hypertension in obesityLeptin levels predict survival in pulmonary arterial hypertension.The heart in obesity-hypertension.Is there an estrogenic component in the metabolic syndrome?Role of leptin in atherogenesis.Detection of thermogenesis in rodents in response to anti-obesity drugs and genetic modification.Obesity and eye diseases.Developmental programming of energy balance and the metabolic syndrome.Why some of us get fat and what we can do about it.Genetic variation within a metabolic motif in the chromogranin a promoter: pleiotropic influence on cardiometabolic risk traits in twins.Obesity cardiomyopathy: pathogenesis and pathophysiology.Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats
P2860
Q27000398-B763890A-AA42-4F50-B2AE-C8F52B431671Q28279771-193B098B-CD40-4D0A-B8A5-0990E318F00BQ28395369-DDE0E7FE-C7C6-4945-9957-F69E80375B80Q28594619-B5E189C6-8AF3-4AD1-B5FB-D236444AFDE3Q30662008-C9782274-224E-4A8E-8FCF-1E88BDA1D012Q33577045-40A48A0D-57B4-4D0A-8B72-FCB388AF7A8BQ33697637-0D41E866-A700-405D-A145-C8019AC8735CQ33803046-15F5099C-A3CF-4F34-8B3E-5B64DE08A062Q33828756-95160550-ABFD-436F-8C4C-48B36F6F37A8Q33928291-F50EAE8C-FEAF-4465-930A-D254D4800263Q33936634-9B4C1BC2-79C3-4730-AC3E-35EAE5B5009FQ33940577-FB0DA122-ED3A-4428-9FEF-B5EC781176F6Q33965361-A7C5F235-BC3A-4CA3-9322-85219C00A47DQ34028132-34E2E2AD-F685-46BE-B659-431D7BE400E2Q34028169-E34A03CB-FECF-4B6A-9E79-CFB0155115DCQ34196401-00F7C734-BA1D-46F4-9EA2-B82B20CA9454Q34415440-49D56C84-6A5D-4191-AE46-E9C96077BE8BQ34434716-7483BE66-D588-44E0-B4BC-B2DE0D1FB85BQ34573045-C3E51973-3696-4E30-AE47-8BD06983AF0FQ35026645-ABE47D07-AF18-426E-8CAE-42ADFD8B039FQ35140191-432B3186-C564-419A-AD47-8B59FE738DC3Q35409635-9BFE60F9-DDCF-4FFC-BD79-9F04EDABC194Q35559531-514B0D53-7A7D-41E8-A03A-5BF1C9CF328EQ35560296-19923E35-9E19-436E-8D3A-FE0FFF3FA190Q35765176-7664085B-1BC6-4C8D-AE24-CC591CA2F2C5Q35829778-26C47CB2-8F71-4570-A636-B33F871713A5Q35850281-A6137F38-97B2-4537-AF4E-D7AB3579D90BQ35889860-608126BD-04A1-4834-8E4A-8C4729ECB3EFQ36012983-3353D650-C6CD-46AE-8CF2-BDC682C7336EQ36108060-4AFB2983-747B-4CA4-96F4-A7374ADDA990Q36216822-7BACF9FE-342E-44CC-B0FB-695BFCE0B9DFQ36267934-16244FD2-AD1D-4DAF-BB4F-BED1079429FDQ36508445-C1B5C371-3361-4919-A39B-DB09505D4948Q36746883-7D603524-ED74-4BE1-8932-0341FD4CA1B3Q36758799-CB3FD9C7-11C7-44B9-B24C-5BB0554F1B6AQ36804827-00B7FC15-48DB-464B-A1D2-DA849238A2BEQ36856241-368D7C88-0445-428F-93DE-ED12876D9A9DQ36876120-B282366E-0384-4251-BC90-469650D46907Q36891890-8E2026B5-10D0-460C-8188-75062D334E19Q37038877-D70434D6-04A6-4FC9-8B97-CDB84735008E
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Sympathetic and cardiorenal actions of leptin.
@en
type
label
Sympathetic and cardiorenal actions of leptin.
@en
prefLabel
Sympathetic and cardiorenal actions of leptin.
@en
P2093
P356
P1433
P1476
Sympathetic and cardiorenal actions of leptin
@en
P2093
P304
P356
10.1161/01.HYP.30.3.619
P407
P433
P577
1997-09-01T00:00:00Z